GSK3787
CAS No. 188591-46-0
GSK3787 ( GSK3787 | GSK-3787 | GSK 3787 )
产品货号. M12948 CAS No. 188591-46-0
GSK3787 是一种选择性且不可逆的 PPARδ 拮抗剂,pIC50 为 6.6,对 hPPARα 或 hPPARγ 没有可测量的亲和力。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥405 | 有现货 |
|
| 10MG | ¥640 | 有现货 |
|
| 25MG | ¥1482 | 有现货 |
|
| 50MG | ¥2633 | 有现货 |
|
| 100MG | ¥4439 | 有现货 |
|
| 500MG | ¥9477 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称GSK3787
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述GSK3787 是一种选择性且不可逆的 PPARδ 拮抗剂,pIC50 为 6.6,对 hPPARα 或 hPPARγ 没有可测量的亲和力。
-
产品描述GSK3787 is as a selective and irreversible antagonist of PPARδ with pIC50 of 6.6, with no measurable affinity for hPPARα or hPPARγ.
-
体外实验GSK3787 is identified as a potent and selective hPPARδ ligand (pIC50=6.6) with no measurable affinity for hPPARα or hPPARγ (pIC50 < 5) in our standard in vitro ligand displacement assay. GSK3787 is inactive against hPPARα and hPPARγ in similar functional antagonist assays. GSK3787 fails to activate the receptor in a standard hPPARδ-GAL4 chimera cell-based reporter assay. GSK3787 is a selective PPARδ antagonist with equipotent species activity against the human and mouse receptor.
-
体内实验GSK3787 has pharmacokinetic properties suitable for use as an in vivo PPARδ antagonist tool compound in mice. GSK3787 is administered intravenously (0.5 mg/kg) and orally (10 mg/kg) to male C57BL/6 mice. Mean clearance (CL) and volume of distribution at steady state (Vss) following iv administration are 39±11 (mL/min)/kg and 1.7±0.4 L/kg, respectively. Following oral administration, good exposure (Cmax=881±166 ng/mL, AUCinf=3343±332 h?ng/mL), half-life (2.7±1.1 h), and bioavailability (F=77±17%) are observed. Oral administration of GSK3787 (10 mg/kg) leads to a serum Cmax of 2.2±0.4 μM in C57BL/6 male mice. Oral administration of GW0742 causes an increase in expression of Angptl4 and Adrp mRNA (known PPARβ/δ target genes) in wild-type mouse colon epithelium, and this effect is not found in Pparβ/δ-null mouse colon epithelium. Coadministration of GSK3787 with GW0742 effectively prevents the ligand-induced expression of both Angptl4 and Adrp mRNA in wild-type mouse colon epithelium, and this effect is not found in Pparβ/δ-null mouse colon epithelium. Oral administration of GSK3787 causes a modest increase in promoter occupancy of PPARβ/δ in the PPRE region of both the Angptl4 and Adrp genes, but coadministration of GSK3787 with GW0742 results in markedly less accumulation of PPARβ/δ in the PPRE region of both the Angptl4 and Adrp genes in wild-type mouse colon epithelium.
-
同义词GSK3787 | GSK-3787 | GSK 3787
-
通路Metabolic Enzyme/Protease
-
靶点PPAR
-
受体PPARδ
-
研究领域Other Indications
-
适应症——
化学信息
-
CAS Number188591-46-0
-
分子量392.78
-
分子式C15H12ClF3N2O3S
-
纯度>98% (HPLC)
-
溶解度DMSO: 79 mg/mL (201.13 mM)
-
SMILESO=C(NCCS(=O)(C1=NC=C(C(F)(F)F)C=C1)=O)C2=CC=C(Cl)C=C2
-
化学全称4-chloro-N-(2-((5-(trifluoromethyl)pyridin-2-yl)sulfonyl)ethyl)benzamide
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Shearer BG, et al. J Med Chem, 2010, 53(4), 1857-186
产品手册
关联产品
-
K-111
K-111 (BM-170744) is an orally available peroxisome proliferator-activated receptor (PPAR)-alpha agonist and insulin enhancer for the study of obesity-type diabetes mellitus and the metabolic syndrome.
-
MCC 555
MCC 555 (Isaglitazone;Netoglitazone;RWJ 241947) 是 PPARγ 的激活配体,EC50 为 8 uM。
-
SR 16832
SR 16832 是一种双位点 PPARγ 抑制剂。它还可以比正位共价拮抗剂 GW 9662 和 T 0070907 更有效地抑制内源配体的结合和 PPARγ 的转录活性。
021-51111890
购物车()
sales@molnova.cn

